rs199734455
Variant summary
The NM_000388.4(CASR):c.308C>T (p.Thr103Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The gene CASR is a tumor suppressor gene (CancerMine: 15 TSG, 15 oncogene, 1 driver citations). The gene CASR is a known oncogene (CancerMine: 15 TSG, 15 oncogene, 1 driver citations). The variant allele was found at a cumulative frequency of 0.0000142 (AC=23) in the gnomAD database across 1,614,196 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.000157. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (no review stars). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.T103S: Uncertain_significance (ClinVar VariationId 4788818, 1 star); p.T103= (synonymous): Likely_benign (ClinVar VariationId 1727556, 2 stars); p.T103= (synonymous): Likely_benign (ClinVar VariationId 532631, 2 stars)
Frequency
Consequence
NM_000388.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal dominant hypocalcemia 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Illumina, Labcorp Genetics (formerly Invitae), ClinGen
- familial hypocalciuric hypercalcemia 1Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, Illumina, ClinGen
- neonatal severe primary hyperparathyroidismInheritance: AR, AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
- autosomal dominant hypocalcemiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, idiopathic generalized, susceptibility to, 8Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- epilepsyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 1 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_000388.4. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CASR | MANE Select | c.308C>T p.Thr103Ile | missense | Exon 3 of 7 | Prot: NP_000379.3 | |
CASR | c.308C>T p.Thr103Ile | missense | Exon 3 of 7 | Prot: NP_001171536.2 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CASR | TSL:1MANE Select | c.308C>T p.Thr103Ile | missense | Exon 3 of 7 | Prot: ENSP00000491584.2 UniProt: | |
CASR | TSL:1 | c.308C>T p.Thr103Ile | missense | Exon 3 of 7 | Prot: ENSP00000420194.1 UniProt: | |
CASR | TSL:5 | c.308C>T p.Thr103Ile | missense | Exon 3 of 7 | Prot: ENSP00000492190.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 6 sources | |||||
GnomAD3 genomes | AF: 0.0000460 | AC:7 | Hom:0 | AN:152198 | Cov:32 |
GnomAD2 exomes | AF: 0.0000159 | AC:4 | AN:251424 | ||
GnomAD4 exome | AF: 0.0000109 | AC:16 | Hom:0 | AN:1461880 | Cov:33 |
GnomAD4 genome | AF: 0.0000460 | AC:7 | Hom:0 | AN:152316 | Cov:32 |
TOPMed (Bravo) | AF: 0.0000378 | AC:10 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.0000343 | AC:7 | Hom:0 | AN:204022 | |
Local & regional cohorts 2 sources | |||||
GenomeAsia100K | AF: 0.000289 | AC:1 | AN:3478 | ||
ToMMo 61KJPN (+60KJPN MNV) | AF: 0.0000160 | AC:2 | Hom:0 | AN:122784 | |
Case/control cohorts
| Cohort | Cases | Controls | ||||
|---|---|---|---|---|---|---|
| AF | AC | AN | AF | AC | AN | |
Epi25 | 0.00 | 0 | 41958 | 0.0000150 | 1 | 66888 |
SCHEMA | 0.0000177 | 2 | 113020 | 0.00000525 | 1 | 190328 |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 30 | |
AlphaMissense | Pathogenic | 0.95 | |
BayesDel_addAF | Pathogenic | 0.23 | D |
BayesDel_noAF | Pathogenic | 0.26 | |
CADD | Uncertain | 24 | |
DANN | Pathogenic | 1.0 | |
DEOGEN2 | Uncertain | 0.70 | D |
Eigen | Pathogenic | 0.84 | |
Eigen_PC | Pathogenic | 0.83 | |
FATHMM_MKL | Pathogenic | 0.97 | D |
FuncVEP CTI | Pathogenic | 0.86 | |
GPN-Star LLR | N/A | -9.7 | |
GPN-Star score | N/A | 9.7 | |
LIST_S2 | Benign | 0.84 | T |
M_CAP | Pathogenic | 0.30 | D |
MetaRNN | Pathogenic | 0.80 | D |
MetaSVM | Uncertain | 0.64 | D |
Mutation Taster | N/A | 33/67 | disease causing |
MutationAssessor | Benign | 1.9 | M |
PhyloP100 | Uncertain | 6.2 | |
popEVE | Benign | -3.6 | |
PrimateAI | Pathogenic | 0.92 | D |
PROVEAN | Uncertain | -3.8 | D |
REVEL | Pathogenic | 0.84 | |
Sift | Uncertain | 0.0060 | D |
Sift4G | Benign | 0.064 | T |
Varity_R | N/A | 0.84 | |
VESM-3B | Benign | -8.7 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.0 | |
SpliceAI score (max) | Benign | 0.010 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.